Latest Conference Articles

Theodore Leng, MD, MS, discusses new findings based on IRIS registry data showing long-term discontinuation trends in patients.

An approval may be pending for the unique delivery system. An expert explains its benefit for nAMD patients and physicians alike.

Dr. Ponder continued his discussion on technology use in pediatric T1D care, focusing on a multidisciplinary care angle and different concepts in treatment.

Investigators reported that machine learning was non-invasive and accessible to a large array of clinicians, and could help prevent infants from developing atopic dermatitis.

Dr. Carbone presented about autism management during the 2021 AAP virtual conference.

Dr. Ponder discusses the importance of both clinician and patient learning about new diabetic technologies, focusing on their utility and limitations in the care process.

Dr. Chan said clinical practice guidelines ideally cover about 75% of patients with ADHD.

A retina care team highlighted positive patient feedback from their makeshift system; could it be a long-term solution?

A greater rate of intravitreal injection appointments were delayed last year, causing worse patient scores in BCVA and OTC.

Dr. Bujoreanu explains how treatments like Cognitive Behavioral Therapy can have a positive impact on chronic pain in pediatric patients.

Dr. Maguiness speaks of new forms of tinea capitis not traditionally seen in the United States, as well as common practices shared between parents and clinicians for the management of several hair and nail disorders.

During this video interview, Dr. Bujoreanu expresses the importance of the multidisciplinary approach of the biopsychosocial model in chronic pain treatment.

Children are now screened for autism at 18 and 24 months.

Dr. Hawryluk noted that acne is estimated to affect 35%-95% of pediatric patients worldwide, though proper diagnosis and treatment of this dermatological condition is possible.

Dr. Owotomo and fellow investigators evaluated 1298 children from the Washington DC area and found that called for greater asthma care by pulmonologists and allergists alike.

Findings from YOSEMITE and RHINE show a significant rate of patients on faricimab were able to extend their dosing to once every 16 weeks after a year of therapy.

Positive phase 1 and 2 findings support an ongoing efficacy assessment of the Ref-1 inhibitor for diabetic retinopathy and diabetic macular edema.

A new cross-sectional analysis from ASRS 2021 show White patients are generally overrepresented in randomized, controlled trials for DME.

Josh Mali, MD, of The Eyes Associates, joins HCPLive to review the key news and developments coming out of the American Society of Retina Specialists 2021 Scientific Meeting.

A cohort assessment of the IRIS registry database shows about 1 in 10 patients to receive anti-VEGF and/or panretinal photocoagulation discontinue therapy for at least 1 year.

Telemedicine will likely continue to be used as a tool in autism management.

In this video interview, Dr. Lee-Kim explains the importance of understanding the results of a Complete Blood Count before rushing to refer a patient to a hematologist.

Dr. Hawryluk speaks of improving upon tolerability of existing therapies for atopic disease as well as promising new therapies on the horizon.

Immigrant children were less likely to be diagnosed with ADHD compared to children of US born parents.

Cohen believes the emergency injection is not only cost-effective but the ideal treatment method for protecting vulnerable pediatric groups with allergies.

The AAP guidelines for ADHD were first released in 2000 and last updated in 2019.

Cohen details some of the diagnostic criteria for anaphylaxis in pediatric populations, differences in symptoms among children and adolescents, and the virtues of epinephrine.

Dr. Michalsky observed challenges in pediatric bariatric surgery, specifically growing consensus on its use, the use of BMI, and access to treatment.